Narrowing the Gap in Managing the Lymphedema of Lymphatic Filariasis. [PDF]
Kazura JW.
europepmc +1 more source
Preclinical animal models for onchocerciasis and loiasis: A systematic review of applications in drug screening. [PDF]
Ayiseh RB +4 more
europepmc +1 more source
Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3. [PDF]
Sinha A +4 more
europepmc +1 more source
Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol. [PDF]
Dinesh RJ +8 more
europepmc +1 more source
Unveiling Dirofilaria Asiatica infection: first clinical insights and treatment challenges for this feline zoonotic parasitosis. [PDF]
Almendros A +4 more
europepmc +1 more source
Beyond business as usual for lymphatic filariasis mass drug administration in hotspot districts. [PDF]
de Souza DK +8 more
europepmc +1 more source
Cross-sectional epidemiological assessment of lymphatic filariasis situation in areas under post-mass drug administration surveillance and the associated risk of transmission in the context of migrants in India: a study protocol. [PDF]
Srividya A +8 more
europepmc +1 more source
Rebound in prevalence and intensity of Onchocerca volvulus infection five years after cessation of alternative treatment strategies in the Massangam Health District, West Region, Cameroon: need for coordinated and sustained efforts. [PDF]
Ondoua Nganjou GS +15 more
europepmc +1 more source
Semi-annual and annual mass drug administration of diethylcarbamazine and albendazole are equally effective regimens for eliminating lymphatic filariasis in Papua New Guinea. [PDF]
Payne MC +9 more
europepmc +1 more source

